New Pyrazolo[1′,5′:1,6]pyrimido[4,5-d]pyridazin-4 (3H)-ones Fluoroderivatives as Human A1 Adenosine Receptor Ligands

被引：0

作者：

Graziano, Alessia ^{[1
]}

Giovannoni, Maria Paola ^{[1
]}

Cilibrizzi, Agostino ^{[1
]}

Crocetti, Letizia ^{[1
]}

Dal Piaz, Vittorio ^{[1
]}

Vergelli, Claudia ^{[1
]}

Trincavelli, Maria Letizia ^{[2
]}

Martini, Claudia ^{[2
]}

Giacomelli, Chiara ^{[2
]}

机构：

[1] Dipartimento Sci Farmaceut, I-50019 Sesto Fiorentino, Italy

[2] Univ Pisa, Dipartimento Psichiatria Neurobiol Farmacol & Bio, I-56126 Pisa, Italy

来源：

ACTA CHIMICA SLOVENICA | 2012年 / 59卷 / 03期

关键词：

Adenosine receptors; A(1) subtype; Ligands; Pyrazolo[1 ',5 ':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones; BEARING POLAR SUBSTITUENTS; POTENT; PHARMACOLOGY; DESIGN;

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

In this paper we report the synthesis and biological evaluation of a new series of pyrazolo[1',5': 1,6] pyrimido[4,5-d]pyridazin-4(3H)-ones as human A(1) adenosine receptor ligands. The tricyclic scaffold was modified at position 6 and 9 by introducing small alkyl chains and substituted phenyls. The most interesting compounds showed Ki for A(1) in the submicromolar range (0.105-0.244 mu M) and the most interesting term (compound 4c) combined an appreciable affinity for A(1) (Ki = 0.132 mu M) with a good selectivity toward A(2A) (43% inhibition at 10 mu M) and A(3) (46% inhibition at 10 mu M).

引用

页码：648 / 655

页数：8

共 20 条

[1] Brown R. A., 2008, J PHARM, V153, P446
[2] Synthesis and pharmacology of pyrido[2,3-d]pyrimidinediones bearing polar substituents as adenosine receptor antagonists
Bulicz, J
Bertarelli, DCG
Baumert, D
Fülle, F
Müller, CE
Heber, D
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (08) : 2837 - 2849
[3] Synthesis, ligand-receptor modeling studies and pharmacological evaluation of novel 4-modified-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as potent and selective human A3 adenosine receptor antagonists
Colotta, Vittoria
Catarzi, Daniela
Varano, Flavia
Lenzi, Ombretta
Filacchioni, Guido
Martini, Claudia
Trincavelli, Letizia
Ciampi, Osele
Traini, Chiara
Pugliese, Anna Maria
Pedata, Felicita
Morizzo, Erika
Moro, Stefano
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (11) : 6086 - 6102
[4] A1 adenosine receptor antagonists, 3-aryl [1,2,4]triazino[4,3-a]benzimidazol-4-(10H)-ones (ATBIs) and N-alkyl and N-acyl-(7-substituted-2-phenylimidazo[1,2-a][1,3,5]triazin-4-yl)amines (ITAs):: Different recognition of bovine and human binding sites
Da Settimo, F
Primofiore, G
Taliani, S
La Motta, C
Novellino, E
Greco, G
Lavecchia, A
Cosimelli, B
Iadanza, M
Klotz, KN
Tuscano, D
Trincavelli, ML
Martini, C
[J]. DRUG DEVELOPMENT RESEARCH, 2004, 63 (01) : 1 - 7
[5] 3-aryl[1,2,4]triazino[4,3-α]benzimidazol-4(10H)-ones:: A new class of selective A1 adenosine receptor antagonists
Da Settimo, F
Primofiore, G
Taliani, S
Marini, AM
La Motta, C
Novellino, E
Greco, G
Lavecchia, A
Trincavelli, L
Martini, C
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (03) : 316 - 327
[6] PYRAZOLO[1',5'-1,6]PYRIMIDO[4,5-D]PYRIDAZIN-7(8H)-ONE - A NEW HETEROCYCLIC RING-SYSTEM FROM ISOXAZOLOPYRIDAZINONES
DALPIAZ, V
CICIANI, G
CHIMICHI, S
[J]. HETEROCYCLES, 1986, 24 (11) : 3143 - 3148
[7] Study to evaluate cardiac hemodynamics and safety of SLV320 in subjects with congestive heart failure
Dohadwala, Mustafa M.
Givertz, Michael M.
[J]. CARDIOVASCULAR THERAPEUTICS, 2008, 26 (04) : 276 - 286
[8] New pyrazolo[1′,5′:1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as potent and selective PDE5 inhibitors
Feixas, J
Giovannoni, P
Vergelli, C
Gavaldà, A
Cesari, N
Graziano, A
Dal Piaz, V
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (09) : 2381 - 2384
[9] Adenosine, mast cells and asthma
Forsythe, P
Ennis, M
[J]. INFLAMMATION RESEARCH, 1999, 48 (06) : 301 - 307
[10] Structure and function of adenosine receptors and their genes
Fredholm, BB
Arslan, G
Halldner, L
Kull, B
Schulte, G
Wasserman, W
[J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2000, 362 (4-5) : 364 - 374

← 1 2 →